Maxigen Biotech Liabilities 2025

Maxigen Biotech Aktienanalyse

What does Maxigen Biotech do?

Maxigen Biotech Inc is a biotechnology company that was founded in 2000. The company, based in San Francisco, California, specializes in the development and production of biotechnological products and solutions. The company's goal is to lead in the biotechnology industry and have a positive impact on the health and well-being of people. To achieve its goals, the company has specialized in four business areas. The first business area is the research and development of new biotechnological products. The company has a team of scientists who work continuously on new innovative technologies and products. The company has already brought several products to market that have been very successful in the biotechnology industry. The second business area is the production of biotechnological products. The company has its own production facility equipped with state-of-the-art technologies. Here, the company's products are manufactured and delivered to customers worldwide. The third business area is the distribution of biotechnological products. The company has built a large distribution network to distribute its products in different parts of the world. The company works closely with pharmacies, laboratories, and hospitals to ensure that its products are made accessible to people. The fourth business area is the application of biotechnological products. The company works closely with doctors and healthcare facilities to ensure that its products are used in medical practice. The company is committed to using its products to improve the health and well-being of people worldwide. Maxigen Biotech Inc has introduced some remarkable products to the market in its history. One of the company's most important products is a highly effective antibiotic used to fight bacterial infections. The company has also developed a medication for the treatment of hypertension that is in high demand worldwide. Additionally, the company has developed a range of products for the treatment of cancer and other serious illnesses. The company has also made a significant contribution to public health. The company has developed technology to lower cholesterol levels in the blood, which can help prevent cardiovascular diseases. The company has also worked on the development of vaccines against infectious diseases that are still prevalent in some regions of the world. Maxigen Biotech Inc has received numerous awards and recognition in its history. The company is known for its innovation and high quality in the production of its products. The company is an example of how the biotechnology industry can contribute to improving the health and well-being of people worldwide. In summary, Maxigen Biotech Inc is a biotechnology company that specializes in the development and production of biotechnological products and solutions. The company has specialized in four business areas: research and development of new products, production of biotechnological products, distribution of biotechnological products, and application of biotechnological products. The company has introduced some remarkable products to the market in its history and has made a significant contribution to public health. The company has received numerous awards and recognition and is an example of excellence in the biotechnology industry. Maxigen Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Maxigen Biotech's Liabilities

Maxigen Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Maxigen Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Maxigen Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Maxigen Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Maxigen Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Maxigen Biotech stock

What is the level of liabilities of Maxigen Biotech this year?

Maxigen Biotech has a debt balance of 207.36 M TWD this year.

What were the liabilities of Maxigen Biotech compared to the previous year?

The liabilities of Maxigen Biotech have increased by 57.23% increased compared to the previous year.

What are the consequences of high debt for investors of Maxigen Biotech?

High liabilities can pose a risk for investors of Maxigen Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Maxigen Biotech?

Low liabilities mean that Maxigen Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Maxigen Biotech affect the company?

An increase in liabilities of Maxigen Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Maxigen Biotech affect the company?

A decrease in the liabilities of Maxigen Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Maxigen Biotech?

Some factors that can influence the liabilities of Maxigen Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Maxigen Biotech so important for investors?

The liabilities of Maxigen Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Maxigen Biotech take to modify the liabilities?

To change its liabilities, Maxigen Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Maxigen Biotech pay?

Over the past 12 months, Maxigen Biotech paid a dividend of 1 TWD . This corresponds to a dividend yield of about 2.27 %. For the coming 12 months, Maxigen Biotech is expected to pay a dividend of 1 TWD.

What is the dividend yield of Maxigen Biotech?

The current dividend yield of Maxigen Biotech is 2.27 %.

When does Maxigen Biotech pay dividends?

Maxigen Biotech pays a quarterly dividend. This is distributed in the months of September, September, October, August.

How secure is the dividend of Maxigen Biotech?

Maxigen Biotech paid dividends every year for the past 2 years.

What is the dividend of Maxigen Biotech?

For the upcoming 12 months, dividends amounting to 1 TWD are expected. This corresponds to a dividend yield of 2.27 %.

In which sector is Maxigen Biotech located?

Maxigen Biotech is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Maxigen Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Maxigen Biotech from 8/16/2024 amounting to 0.999 TWD, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Maxigen Biotech pay the last dividend?

The last dividend was paid out on 8/16/2024.

What was the dividend of Maxigen Biotech in the year 2024?

In the year 2024, Maxigen Biotech distributed 0.476 TWD as dividends.

In which currency does Maxigen Biotech pay out the dividend?

The dividends of Maxigen Biotech are distributed in TWD.